HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schaefer, E. J. Articles by Berson, E. L. Search for Related Content PubMed PubMed Citation Articles by Schaefer, E. J. Articles by Berson, E. L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1427-1433, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa

EJ Schaefer, SJ Robins, GM Patton, MA Sandberg, CA Weigel-DiFranco, B Rosner and EL Berson
Department of Medicine, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111, USA.

In order to test the hypothesis that retinitis pigmentosa (RP) is associated with fatty acid abnormalities within cell membrane phospholipids, red blood cell membrane (RBC) phosphatidylethanolamine (PE) fatty acid content (% of total fatty acids) was measured using high performance liquid chromatography and capillary column gas chromatography in 155 patients from separate families with different genetic types of RP and 101 normal subjects. After controlling for the effects of age and sex, patients with all genetic forms of RP had significantly (P < 0.001) reduced mean RBC PE 22:6 omega 3 (n-3) (docosahexaenoic acid, DHA) content, and significantly (P < 0.001) elevated mean RBC PE dimethyl acetal (DMA) forms of 16:0, 18:0, and 18:1 omega 9 (n-9) as compared with normal subjects. RBC PE content of 22:5 omega 3 (n-3) (a precursor to DHA) and 18:2 omega 6 (n-6) (the major dietary essential fatty acid) were not significantly different in RP than in controls. Analysis by genetic types of RP showed that the mean RBC PE DHA percentages were significantly reduced by 24%, 14%, 30%, and 17%, respectively, in dominant, recessive, X-linked, and isolate forms of RP. The relative amounts of plasmalogens as indicated by DMA forms of 16:0 and 18:0 were significantly (P < 0.01) increased in dominant (by 33% and 25%), recessive (by 36% and 25%), and isolate cases (by 32% and 26%) of RP as compared with normal subjects. No such differences were seen in X-linked cases versus controls. Our data indicate that RBC PE DHA content is decreased in all genetic types of RP patients as compared to control subjects, and that RBC PE plasmalogens are increased in dominant, recessive, and isolate forms of RP. These data raise the possibility that membrane phospholipid fatty acid abnormalities may contribute to the pathogenesis of RP.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. G. Bazan Homeostatic Regulation of Photoreceptor Cell Integrity: Significance of the Potent Mediator Neuroprotectin D1 Biosynthesized from Docosahexaenoic Acid The Proctor Lecture Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4866 - 4881. [Full Text] [PDF]

				E. J. Schaefer, V. Bongard, A. S. Beiser, S. Lamon-Fava, S. J. Robins, R. Au, K. L. Tucker, D. J. Kyle, P. W. F. Wilson, and P. A. Wolf Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study Arch Neurol, November 1, 2006; 63(11): 1545 - 1550. [Abstract] [Full Text] [PDF]

				E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-DiFranco, A. Moser, R. J. Brockhurst, K. C. Hayes, C. A. Johnson, E. J. Anderson, A. R. Gaudio, et al. Clinical Trial of Docosahexaenoic Acid in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment Arch Ophthalmol, September 1, 2004; 122(9): 1297 - 1305. [Abstract] [Full Text] [PDF]

				D. H. Wheaton, D. R. Hoffman, K. G. Locke, R. B. Watkins, and D. G. Birch Biological Safety Assessment of Docosahexaenoic Acid Supplementation in a Randomized Clinical Trial for X-Linked Retinitis Pigmentosa Arch Ophthalmol, September 1, 2003; 121(9): 1269 - 1278. [Abstract] [Full Text] [PDF]

				E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF]

				D. R. Hoffman, J. C. DeMar, W. C. Heird, D. G. Birch, and R. E. Anderson Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa J. Lipid Res., September 1, 2001; 42(9): 1395 - 1401. [Abstract] [Full Text] [PDF]

				R. E. Anderson, M. B. Maude, and D. Bok Low Docosahexaenoic Acid Levels in Rod Outer Segment Membranes of Mice with rds/Peripherin and P216L Peripherin Mutations Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1715 - 1720. [Abstract] [Full Text] [PDF]

				Y. Li, I. Marcos, S. Borrego, Z. Yu, K. Zhang, and G. Antinolo Evaluation of the ELOVL4 gene in families with retinitis pigmentosa linked to the RP25 locus J. Med. Genet., July 1, 2001; 38(7): 478 - 480. [Full Text]

				E. Cho, S. Hung, W. C Willett, D. Spiegelman, E. B Rimm, J. M Seddon, G. A Colditz, and S. E Hankinson Prospective study of dietary fat and the risk of age-related macular degeneration Am. J. Clinical Nutrition, February 1, 2001; 73(2): 209 - 218. [Abstract] [Full Text] [PDF]